Application
TWS119 has been used as glycogen synthase kinase-3β (GSK-3β) GSK3β inhibitor.
Biochem/physiol Actions
TWS119 favors the γδT cells survival and proliferation by activating the mammalian target of rapamycin (mTOR) pathway. It also promotes the expression of T-cell factor 1 (TCF1) and modulates cytokine production.
TWS119 is a potent Glycogen synthase kinase-3β (GSK-3β) inhibitor that can induce neurogenesis in embryonic stem cells (ESCs).
- UPC:
- 12141747
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML1271-5MG
- CAS:
- 601514-19-6
akash.verma@cenmed.com
(732) 447-1115





